Trial Profile
Rituximab for the Treatment of Rheumatoid Arthritis-Associated Interstitial Pneumonia: A Pilot Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Nov 2014
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Interstitial lung diseases; Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 06 Feb 2012 Actual patient number 10 added as reported by ClinicalTrials.gov.
- 06 Feb 2012 Actual end date Jun 2011 added as reported by ClinicalTrials.gov.
- 06 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.